Skip to main content
Top
Published in: Intensive Care Medicine 12/2016

01-12-2016 | Correspondence

Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis

Authors: Otavio T. Ranzani, Gianluigi Li Bassi, Antoni Torres

Published in: Intensive Care Medicine | Issue 12/2016

Login to get access

Excerpt

Dear Editor, …
Appendix
Available only for authorised users
Literature
1.
go back to reference Ayzac L, Girard R, Baboi L, Beuret P, Rabilloud M, Richard JC, Guerin C (2016) Ventilator-associated pneumonia in ARDS patients: the impact of prone positioning. A secondary analysis of the PROSEVA trial. Intensive Care Med 42:871–878. doi:10.1007/s00134-015-4167-5 CrossRefPubMed Ayzac L, Girard R, Baboi L, Beuret P, Rabilloud M, Richard JC, Guerin C (2016) Ventilator-associated pneumonia in ARDS patients: the impact of prone positioning. A secondary analysis of the PROSEVA trial. Intensive Care Med 42:871–878. doi:10.​1007/​s00134-015-4167-5 CrossRefPubMed
2.
go back to reference Wolkewitz M, Cooper BS, Bonten MJ, Barnett AG, Schumacher M (2014) Interpreting and comparing risks in the presence of competing events. BMJ 349:g5060CrossRefPubMed Wolkewitz M, Cooper BS, Bonten MJ, Barnett AG, Schumacher M (2014) Interpreting and comparing risks in the presence of competing events. BMJ 349:g5060CrossRefPubMed
5.
go back to reference Bhaskaran K, Rachet B, Evans S, Smeeth L (2013) Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.01.007.: beta-blockers and prostate cancer survival–interpretation of competing risk models. Eur Urol 64:e86–e87CrossRefPubMed Bhaskaran K, Rachet B, Evans S, Smeeth L (2013) Re: Helene Hartvedt Grytli, Morten Wang Fagerland, Sophie D. Fosså, Kristin Austlid Taskén. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease. Eur Urol. In press. http://​dx.​doi.​org/​10.​1016/​j.​eururo.​2013.​01.​007.​: beta-blockers and prostate cancer survival–interpretation of competing risk models. Eur Urol 64:e86–e87CrossRefPubMed
Metadata
Title
Prone position and VAP incidence in the PROSEVA trial: attention to the causal question when interpreting competing risk analysis
Authors
Otavio T. Ranzani
Gianluigi Li Bassi
Antoni Torres
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 12/2016
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-016-4469-2

Other articles of this Issue 12/2016

Intensive Care Medicine 12/2016 Go to the issue

Imaging in Intensive Care Medicine

An unusual, iatrogenic cause of massive airleak

Correspondence

Tardive tachypnea